Zomedica Pharmaceuticals Corp.(TSX Venture Exchange : ZOM)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.10% | 129.67 | 0.7% | $917.03m | |
| PFE | Pfizer Inc. | -0.87% | 36.51 | 0.9% | $717.72m | |
| MRK | Merck & Co., Inc. | 0.59% | 82.51 | 0.7% | $595.56m | |
| ABBV | AbbVie, Inc. | 1.45% | 71.60 | 2.3% | $552.44m | |
| BMY | Bristol-Myers Squibb Company | 0.55% | 49.74 | 1.4% | $445.88m | |
| LLY | Eli Lilly and Company | 0.91% | 111.13 | 1.0% | $325.26m | |
| AZN | AstraZeneca PLC Sponsored ADR | 1.48% | 43.14 | 1.2% | $143.14m | |
| NVS | Novartis AG Sponsored ADR | 0.46% | 86.54 | 0.2% | $132.47m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | 1.21% | 41.09 | 0.3% | $82.16m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | 3.01% | 50.97 | 0.1% | $69.36m | |
| SNY | Sanofi Sponsored ADR | 1.61% | 44.30 | 0.2% | $54.12m | |
| LCI | Lannett Company, Inc. | 2.38% | 13.76 | 35.6% | $51.84m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | 1.52% | 2.01 | 1.6% | $2.23m | |
| EPIX | ESSA Pharma Inc | -1.67% | 2.95 | 0.1% | $0.18m |
Company Profile
Zomedica Pharmaceuticals Corp. engages in the discovery, development and commercialization of pharmaceuticals for the companion pet. The company was founded by Gerald L. Solensky, Jr. on January 7, 2013 and is headquartered in Ann Arbor, MI.